ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosa.

Nair, Archana A; Marmor, Michael F

Nair, Archana A; Marmor, Michael F.

Affiliation

Nair AA; Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, 94303-3216, CA, USA.
Marmor MF; Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, 94303-3216, CA, USA. marmor@stanford.edu.

Doc Ophthalmol ; 134(3): 175-183, 2017 06.

Article in En | MEDLINE | ID: mdl-28451987

Subject(s)

Electroretinography; Enzyme Inhibitors/adverse effects; Hydroxychloroquine/adverse effects; Retinal Diseases/diagnosis; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Photoreceptor Cells, Vertebrate/physiology; Retinitis Pigmentosa/diagnosis; Retrospective Studies; Visual Fields

Key words

Drug toxicity; Electroretinogram; Hydroxychloroquine retinopathy; Pericentral retinitis pigmentosa; Retinitis pigmentosa

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Electroretinography / Enzyme Inhibitors / Hydroxychloroquine Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Doc Ophthalmol Year: 2017 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google